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Objective: Microvascular incompetence after ischemia and reperfusion may com-
promise the normal postischemic coronary perfusion and additionally jeopardize
the recovery of the myocytes. We investigated whether such a form of acute
endothelial dysfunction occurs in the routine operative setting despite the use of
protective measures. For this purpose, we measured pressure-flow relations in the
coronary vasculature during heart operations before and after ischemia and after
reperfusion and their reaction to the nitric oxide donor nitroglycerin.
Methods: Forty-eight patients with a low risk profile scheduled for routine coronary
artery bypass surgery were included. During normothermic extracorporeal circula-
tion, the fibrillating heart was completely excluded from bypass by clamping of the
ascending aorta and snaring of the caval veins. It was relieved of blood by opening
the right atrium and venting the left atrium and ventricle to avoid distention. The
coronary vessels were perfused under controlled flow, and the perfusion pressures
were monitored. This protocol was performed in 24 patients before and immediate-
ly after ischemia and after a reperfusion period.
Results:  Compared with the preischemic control, vascular resistance was decreased
by 17% (P < .003) immediately after ischemia but increased again by 46% (P <
.0001) during an average of 25 minutes of reperfusion and, even more important, by
23% (P < .028) in comparison with the preischemic values. In two groups of 12
patients, nitroglycerin was added to the perfusate either in a dosage of 3 µg · kg ·
min–1 or as a bolus injection of 2 mg. Low-dose nitroglycerin did not reduce the ele-
vated postreperfusion resistances significantly, but bolus injection did (P < .0002).
Coronary vessel resistance increased during reperfusion in particular in patients
with a history of hypertension.
Conclusion: Coronary vasoconstriction during postischemic reperfusion is regular-
ly present in the routine operative setting in cardiac surgery, despite myocardial pro-
tection measures. The amount of vasoconstriction varies considerably and is partic-
ularly increased in patients with hypertension. The nitric oxide donor nitroglycerin
can normalize the elevated resistances, but only in high dosages. This demonstrates
a preserved ability of vascular smooth muscle to relax. The phenomenon had no
sequelae in our low-risk patients having elective operations. However, it may gain
significance in the case of severe left heart hypertrophy and in patients at risk with
both a postoperative low-output syndrome and reduced mean arterial pressures dur-
ing reperfusion.
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Clinical efforts in cardiac surgery pertinent tothe effects of ischemia and reperfusion con-centrate predominantly on myocytes andthe contractile function of the heart.Laboratory research has also focused on theendothelium and the microvasculature as
targets for injuries during ischemia and reperfusion.1-5
Endothelial dysfunction can lead to microvascular incompe-
tence with elevated vascular tone and may in consequence
compromise the return of normal postischemic coronary
perfusion.6 Depending on the amount and time course of the
elevated resistance, the recovery of the myocytes will be
jeopardized. Because animal models of coronary artery dis-
ease cannot easily be transferred to human beings7 and ex
vivo investigations do not necessarily reflect reality, studies
must also be performed under clinical conditions in human
beings.
Resistance in the coronary vasculature is influenced by
stenosis of the epicardial arteries, wall tension of the
myocardium, particularly of the left ventricle, blood viscos-
ity, but most importantly, by the tone of the small arteries.
This multitude of factors presents interpretive limitations
when changes in coronary vascular resistance are investi-
gated in vivo. Bypass operations, on the other hand, offer a
reproducible standard situation with respect to ischemia,
reperfusion, and myocardial protection measures. Wall ten-
sion of the myocardium and blood viscosity can be kept
constant to a wide extent. Stenoses of the epicardial arteries
remain unchanged during surgery. Thus, an intraindividual
analysis of the vascular reactions to ischemia and reperfu-
sion and of the responses to defined pharmacologic inter-
ventions is possible.
The purpose of the present clinical investigation was to
examine the response of the human coronary vascular resis-
tance to ischemia and reperfusion when crystalloid cardio-
plegic solution is used for myocardial protection and to
evaluate the effectiveness of the nitric oxide donor nitro-
glycerin (NTG) in lowering elevated resistances.
Methods
Patient Population
Forty-eight consecutive patients (Table 1) scheduled for elective
bypass surgery with a similar pattern of stenosis of the coronary
arteries were included in a prospective study. Forty-one of them
had triple vessel disease and 7, double vessel disease. The left ante-
rior descending and right coronary arteries were always involved
(stenosis ≥ 70%), and 6 patients had a main stem stenosis of 50%
to 60%. Aspirin had been discontinued 7 days before the operation.
Patients with accompanying valvular disease, an ejection fraction
below 30%, unstable angina, myocardial infarction within 4 weeks
before the operation, and with emergency operations were exclud-
ed from the study. A history of severe or long-lasting hypertension,
left ventricular hypertrophy of any other reason,8 insulin-depen-
dent diabetes,9 main stem stenosis of more than 80%, and occlu-
sion of the left anterior descending or right coronary artery and left
circumflex coronary artery together were also exclusion criteria,
because these factors may influence the coronary resistance inde-
pendently of the study design. Patients with severe calcifications of
the ascending aorta were excluded for technical reasons.
Study Protocol
A standard protocol of anesthesia was used throughout the oper-
ative procedure, consisting of pancuronium and ventilation with
enflurane (0.8%-1.0% inspired), supplemented with additional
doses of fentanyl (0.1-0.2 mg). Extracorporeal circulation
(ECC) was instituted by means of bicaval and aortic arch can-
nulation. The priming volume of the ECC consisted of 2500 mL
of Ringer’s solution. If additional volume was needed during
ECC, packed red blood cells and Ringer’s solution were added
to maintain the levels of hemoglobin and hematocrit constantly
(hemoglobin 8.4 ± 0.8 g/dL, hematocrit 24.8% ± 2.2%). Thus,
relevant changes in blood viscosity were avoided. Any addition-
al infusions or medications were abandoned. PO2, PCO2, and pH
in the arterial perfusate were kept constant to avoid effects on
vascular tone. Complete cardiac relief during all measurements
was achieved by venting the left atrium and ventricle and open-
ing the right atrium while the caval veins were occluded. Thus,
wall tension was constantly low. An additional cannula (3.2 mm
diameter; Sherwood Medical, Tullamore, Ireland) was inserted
into the ascending aorta. This cannula was connected to the car-
diotomy reservoir by a separate perfusion line. A small roller
pump (Stöckert, Munich, Germany) enabled a flow-controlled
perfusion through this line. During the measurements, the
ascending aorta was clamped distal to this cannula. Thus, the
flow through this cannula represented the blood volume entering
the coronary arteries that a competent aortic valve provided.
This was ensured by preoperative echocardiography in all
patients. In the early phase of the study, we assessed aortic valve
competence during data acquisition by intraoperative trans-
esophageal echocardiography. The aortic root pressure, now rep-
resenting the coronary perfusion pressure, was monitored during
the measurements.
Blood samples for evaluation of the metabolic condition of the
myocardium was obtained at flow levels of 300 mL · min–1, that is,
70 to 100 seconds after the onset of reperfusion.
During cardiac arrest, tantamount to the duration of myocar-
dial ischemia, coronary revascularization was performed. Arrest
was induced by pressure-controlled administration of 4°C cold
Bretschneider’s cardioplegic solution (F. Köhler Chemie,
Bergheim, Germany) given once in a dosage of 25 mL/kg body
weight at a pressure of 60 mm Hg. This represented the total
amount of cardioplegic solution given. Blood temperature was
lowered to 30°C during the first 20 minutes of ischemia, and
then rewarming was started. Thus, both the arterial blood and the
core temperature were normothermic at the onset of myocardial
reperfusion. Mean clamping time was 46.4 ± 7.9 minutes.
During reperfusion, the proximal anastomoses were constructed
during aortic side clamping. Mean reperfusion time averaged
25.0 ± 4.4 minutes.
The study protocol was approved by the institutional ethics
committee, and informed consent was obtained from each patient
before the operation. 
Cardiopulmonary Support and Physiology Kalweit et al
1012 The Journal of Thoracic and Cardiovascular Surgery • November 2001
Kalweit et al Cardiopulmonary Support and Physiology
TX
CS
P
CS
P
A
CD
CH
D
G
TS
ED
IT
O
RI
A
L
Measurements
All coronary flow studies were performed with normothermic
blood on the completely relaxed and fibrillating heart. In 24
patients the measurements were performed at 3 time points: 10
minutes after the starting of ECC (control value), at the end of
ischemia, that is, when cardiac perfusion was reinstituted (early
reperfusion), and after an average reperfusion period of 25 minutes
(late reperfusion). Perfusion was started with a flow rate of 100 mL
· min–1 and was increased in 100-mL steps up to 300 mL · min–1.
The time needed to obtain constant pressure levels at given flows
was 10 to 25 seconds. In 8 patients, the protocol was repeated in
decreasing steps to confirm that the pressure levels were repro-
ducible and did not depend on the preceding flow range. The flow
protocols were identically repeated at the 3 time points, thus allow-
ing a direct comparison of the results obtained. Measurements with
stepwise increases in pump flow were chosen to avoid an acute
volume load to the coronary vasculature that might provoke
unforeseeable reactions of the small arteries. The already anasto-
mosed bypasses remained clamped at late reperfusion. So that an
autoregulatory dilatation of the coronary arteries could be avoided
at the time points control value and late reperfusion as a result of
complete interruption of flow after clamping of the aorta, blood
circulation was maintained by initiating the flow through the addi-
tional cannula before the aorta was clamped.
A second series of 24 patients was randomly divided into two
groups. In group I the nitric oxide donor NTG was added in a sec-
ond step to the coronary perfusate during control and late reperfu-
sion at a dose of 3 µg · kg · min–1 (normal-dose NTG) while per-
fusion was maintained at a flow rate of 300 mL · min–1. In group
II the protocol was identical, but the NTG dose applied consisted
of a 2-mg bolus (high-dose NTG) injected into the running coro-
nary perfusate.
Statistical Analysis
For statistical evaluation, the pressures were standardized by sub-
tracting the preischemic values from the ones immediately after
ischemia and during reperfusion and by subtracting the values
without NTG from the ones with NTG. Thus, the interindividual
variability was kept at the smallest possible level. For these differ-
ences, a 2-factorial analysis of variance with repeated measure-
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TABLE 1. Demographic characteristics of 48 patients
Sex (M/F) 39/9
Age (y) 67.7 ± 8.6
Current smoker 11
Total cholesterol > 240 mg/dL 12
Non–insulin-dependent diabetes 10
Moderate hypertension 9
Double vessel disease 7
Triple vessel disease 41
Data are means ± SD or number of patients.
Figure 1. Interaction between pressure and flow at different time points (control value, early reperfusion, and late
reperfusion) and for 3 different flow rates (100, 200, and 300 mL · min–1) (n = 24). At 300 mL · min–1, coronary resis-
tance decreased significantly at early reperfusion compared with the control value (P < .003), increased until late
reperfusion with regard to early reperfusion (P < .0001), and was significantly higher comparing control value and
late reperfusion (P < .028). ctr value, Control value before ischemia; early rep, early reperfusion immediately after
ischemia; late rep, late reperfusion after an average of 25 minutes of reperfusion.
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ments was performed with the use of the PROC GLM of the SAS
package for statistical analysis (SAS Institute, Inc, Cary, NC), with
the one factor being time and the other being flow (100, 200, or
300 mL · min–1); in the second series, one factor was time and the
other was NTG (3 µg · kg · min–1 or 2-mg bolus injection). We
chose a model with repeated measurements. Data are expressed as
mean and SD.
Results
In 24 patients, the hemodynamic measurements were per-
formed at the 3 time points described with flow rates of 100,
200, and 300 mL · min–1. Given normal heart weights in all
subjects, 300 mL · min–1 represents a flow range of 0.5 to
0.8 mL · g · min–1. Preoperative echocardiographic evalua-
tion showed normal cardiac dimensions in the study cohort,
which can be sufficiently correlated to normal heart weight.
As expected, pressures differed significantly during any
time of measurement (control value, early reperfusion, and
late reperfusion) at the 3 flow rates (100, 200, and 300 mL ·
min–1). With regard to the different time points, a significant
“time effect” at 300 mL · min–1 was found comparing the
standardized pressures (see “Statistical Analysis”) at control
value → early reperfusion, control value → late reperfusion,
and early reperfusion → late reperfusion; the levels of sig-
nificance were P < .003, P < .028, and P < .0001 (Table 2).
A significant interaction between the 2 factors (time point
and flow) with respect to the vessel resistance was not
detected. Figure 1 depicts the course of pressures at the 3
time points for a flow of 100, 200, and 300 mL · min–1 in 24
patients. It is obvious that only “physiologic” flows of 300
mL · min–1 give reproducible and comparable results.
In another 12 patients, NTG (3 µg · kg · min–1, normal-
dose NTG) was added in a second step to the perfusate at the
time points control value and late reperfusion during mea-
surement with a flow rate of 300 mL · min–1. A minimal
pressure reduction took place at both time points, in partic-
ular at late reperfusion (Figure 2), which was not statistical-
ly significant. In another 12 patients, an NTG bolus injec-
tion of 2 mg (high-dose NTG) was applied at the time points
control value and late reperfusion. Significant reductions of
perfusion pressures resulted (P < .05 at control value and P
< .0002 at late reperfusion). The levels at late reperfusion
reached the control levels without NTG or went below the
control levels (Figure 3).
A repeat retrospective assessment of the stenosis pattern
in the coronary angiograms did not demonstrate any corre-
lation between the cumulative degree of stenosis in all dis-
eased vessels and behavior of the resistance.
Relevant metabolic influences on the measurements at
control value and late reperfusion caused by PO2, PCO2, pH,
and lactate levels in the perfusate could be excluded (Table
3). The lactate levels in the coronary sinus blood showed an
increase above the arterial level at the beginning of reperfu-
sion, reflecting the ischemia-induced acceleration of anaer-
obic glycolysis. Return to lactate extraction at late reperfu-
sion demonstrated the reconsolidation of mitochondrial
oxidative phosphorylation.
Discussion
To the best of our knowledge, this study shows for the first
time in patients undergoing cardiac surgery the development
of an increasing hypercontraction of the coronary vascula-
ture during postischemic reperfusion, strongly resembling
the phenomenon of “vascular stunning.” The significant
increase of coronary resistances was demonstrated by
means of a standardized protocol. It occurred despite
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TABLE 2. Coronary perfusion pressures (mm Hg) at the 3 flow rates before ischemia and standardized pressure differences
(mm Hg) at a flow rate of 300 mL · min–1
Coronary perfusion pressure (mm Hg) 100 mL · min–1 flow 200 mL · min–1 flow 300 mL · min–1 flow
Time points 
I 42 ± 11 62 ± 17 77 ± 20
II 35 ± 13 51 ± 14 65 ± 15*†
III 44 ± 10 67 ± 21 95 ± 30*‡§
Standardized pressure differences (mm Hg) at a flow of 300 mL · min–1
I → II –12 ± 14*
I → III 18 ± 15*
II → III 30 ± 20*
I, Control values before ischemia; II, early reperfusion immediately after ischemia; III, values after a reperfusion period of 24 ± 5 minutes. The standard
pressure differences were measured in 24 patients without pharmacologic intervention (for further explanation see text). Data are expressed as means ±
SD.
*P values indicate significant differences between groups at the flow rate of 300 mL · min–1.
†I versus II, P < .003.
‡I versus III, P < .028.
§II versus III, P < .0001.
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myocardial protection via effective cardioplegia. A rise was
present in all patients but varied considerably, although the
study population was rather homogeneous with respect to
cardiac and vascular state.
Addition of the endothelium-independent agent NTG to
the coronary perfusate in otherwise systemically applicable
doses had only minimal influence on the increased resis-
tances, but bolus application abolished it completely, indi-
cating a preserved ability of vascular smooth muscle to
relax.
Critique of Methods
Global coronary resistance is not routinely measured in
human beings. Some pitfalls must be excluded to obtain
reliable results:
1. The vascular resistance depends on the intramural
wall tension. Thus, all measurements were performed
on unloaded and nonworking hearts to ensure a ten-
sion level as low and constant as possible. 
2. The viscosity of the perfusate was maintained by the
use of blood with a constant hematocrit value. 
3. Coronary flow will clearly depend on heart weight.
Major influence resulting from different heart weights
was minimized by excluding patients with ventricular
hypertrophy. Nevertheless, one portion of the large
variation in resistances might contribute to the lack of
standardizing coronary flows because of differences
in heart weight, which depend on the body weight. 
4. Other factors contributing to the considerable vari-
ance in the results are both the modified vasodilatory
capacity in atherosclerotic coronary arteries10,11 and
the varying severity of stenoses in the coronary vas-
culature. To exclude a major effect of the latter factor,
we included only patients with a comparable stenosis
pattern. 
5. Another factor is the dependency of myocardial pro-
tection on imbalances of cardioplegic distribution due
to coronary stenosis and locally different coronary
vessel tone. 
6. So that metabolically induced effects on the vascular
tone could be excluded, the perfusate was in like man-
ner oxygenated throughout the protocol. 
7. Time-dependent factors are negligible because dura-
tion of both ischemia and reperfusion was kept with-
in a narrow interval. 
8. A nonphysiologic method, measurements on a fibril-
lating heart, had to be chosen because intraoperative
measurements on a beating heart proved to be very
time consuming to reach a steady state. They were
abandoned because of ethical reasons.
From a clinical point of view, the study had no influence
on outcome. The postoperative course of all patients was
uncomplicated, with only 18 patients requiring modest
dobutamine administration for a maximum of 24 hours post-
operatively. Before and during measurements, no cate-
cholamines were given.
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Figure 2. Perfusion pressures in 12 patients at 2 time points (control value and late reperfusion) without nitro-
glycerin and effect of 3 µg · kg · min–1 nitroglycerin on elevated pressures during late reperfusion, demonstrating
minimal changes (not significant). control, Control value before ischemia; late reperfusion, values after a reper-
fusion period of 24 ± 5 minutes; NTG, nitroglycerin.
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Vascular Hypercontraction
The ventricular function remains depressed after ischemia
during reperfusion (myocardial stunning).12 The current
opinion in basic research defines stunning in a broader
sense, not only encompassing contractile function. Thus,
terms like metabolic stunning13 and vascular stunning14
were coined. A variety of factors are blamed for this phe-
nomenon, a prominent one being the endothelium.4,15 In a
number of in vitro and in vivo animal experiments, the
coronary flow reserve was decreased during reperfusion
as a consequence of a hypercontractile vasculature. In
canine hearts that were subjected to 90 minutes of
ischemia, the flow reserve was decreased during 1 week.5
Elevated endothelium-dependent hypoxic factors indicat-
ing endothelial injury can persist for up to 12 weeks.16
Endothelial dysfunction leads to impaired coronary
vasorelaxation as early as 2.5 minutes after the onset of
reperfusion and aggravates the condition during the next
20 minutes.17 To avoid such time-dependent changes in
this study, we performed the measurements 20 to 30 min-
utes after the onset of reperfusion. Any damage to the
endothelial surface could be excluded by scanning elec-
tron microscopy,16 and it was shown that the postischemic
endothelial dysfunction seems to particularly affect the
intramyocardial resistance vessels,18 although in another
study no significant differences between epicardial and
endocardial microvascular responses to endothelium-
dependent agents were seen.19
On the other hand, more mechanistic factors may also
play a role, such as microvascular compression caused by
both increased cross-sectional area of sarcomeres and intra-
cellular edema.20 Other discussed factors are activated coag-
ulation,21,22 complement activation,23 induction of leuko-
cyte adhesion molecules,24-26 and procoagulant factors.27
Furthermore, the increased release of vasoconstrictive
agents28,29 and the decreased release of nitric oxide4,30 are
discussed.
In contrast to most of the aforementioned experiments,
the present study had to consider cardioplegia for myocar-
dial protection. In rats, use of cardioplegic solutions permit-
ted vascular stunning only after prolonged periods of
ischemia, longer than those required to observe contractile
dysfunction.31 Our study aimed at the question of whether
the reactions of the vasculature to ischemia and reperfusion
known from animal experiments are similar in human
beings despite the use of standardized measures of myocar-
dial protection. The protection conferred via cardioplegia in
our human study was not complete, because vascular resis-
tance (coronary vascular hypercontraction) was markedly
increased. The measurements at lower flows (100 and 200
mL · min–1) showing only minor changes in resistances
demonstrate that vascular hypercontraction is indeed the
causal factor, because elevated wall tension or external pres-
sure by cellular edema would be even more important at
lower flows. A vasomotor response similar to our human
findings was obtained in a pig model.32
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Figure 3. Perfusion pressures in 12 patients at 2 time points (control value and late reperfusion) without nitro-
glycerin and effect of a 2-mg bolus of nitroglycerin on elevated pressures during late reperfusion, demonstrating
a significant decrease in resistances (P < .0002). control, Control value before ischemia; late reperfusion, values
after a reperfusion period of 24 ± 5 minutes; NTG, nitroglycerin.
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Clinical Relevance
Only patients with a low risk profile were included to avoid
unnecessary complications during the protocol and to
exclude factors that might have additional effects on the
results. In these patients, the coronary resistance was
increased during early reperfusion, thus impeding coronary
inflow (ie, oxygen supply). Animal experiments have clear-
ly demonstrated that the reduced oxygen supply additional-
ly jeopardizes the already impaired ventricular function.33
Thus, the possibility that a widely used agent like NTG
might have an effect on this vasoconstriction is of major
interest. With systemically applicable dosages, only a slight
decrease in coronary vascular resistance occurred before
ischemia-reperfusion, that is, during control investigation.
When reperfusion after ischemic cardiac arrest had led to
elevated resistances, normal-dose NTG had the same mini-
mal influence on it, but bolus injection proved that the vas-
cular smooth musculature was still able to relax. The above
changes in coronary vascular resistances took place despite
use of crystalloid cardioplegia for cardiac protection.
In patients with a more complex risk profile, including
severe hypertension, diabetes, hyperlipidemia, heavy smok-
ing, and markedly impaired ventricular function, an increas-
ing microvascular incompetence during reperfusion will
likely play a more crucial role.34 In turn, the coincidence of
a number of risk factors like myocardial hypertrophy, pro-
longed preceding ischemia, and myopathies in combination
with an impaired postischemic coronary perfusion may lead
to self-promoting heart failure that might even be fatal.
It would be helpful to identify high-risk patients before
surgery so that appropriate measures could be taken.
Because the impaired vasorelaxation seems to be endotheli-
um dependent,17,18 lowering the vascular tone via endothe-
lium-independent agents should be advantageous but is not
feasible with normal-dose NTG. The dosages needed cannot
be applied systemically.
Mild Hypertension
The coronary resistances after the 25-minute reperfusion
period were elevated to a greater degree in 9 patients than in
the remaining 39 patients of the study group. Reanalysis of
the risk profiles showed that these 9 patients all had a longer
history of mild hypertension that was, however, not yet
associated with left ventricular hypertrophy. Hypertension
not only promotes the development of atherosclerosis but
also leads to the disruption of normal endothelial func-
tion.34-36 The elevated resistances could be due to a higher
wall tension or to a more impaired endothelium-dependent
relaxation. The pattern of stenoses in the epicardial coro-
nary arteries cannot explain the different resistances
because they were almost identical in all patients. On the
other hand, the resistances during early reperfusion were
markedly decreased in these patients, demonstrating an
excellent dilatory reserve. In consequence, the results from
this subgroup with an otherwise relatively low risk profile
suggest that attention must be paid in patients with known
hypertension to secure adequate coronary inflow during
reperfusion. Not only a sufficient cardiac output, but also an
adequate pressure level will be important.
Conclusions
The findings from animal experiments can be transferred to
the human coronary vasculature, that is, the coronary resis-
tance in patients with open chest surgery rises after ischemia
during early reperfusion. Such “vascular hypercontraction”
happened although the heart was protected with cardio-
plegic solution. Similar studies performed with other forms
of cardiac protection are necessary to rule out the weight of
the cardioplegia technique on coronary resistances. In rou-
tine surgery on patients with a low risk profile, the
microvascular incompetence after ischemia/reperfusion
does not impair the functional recovery. However, the
reduced oxygen supply will likely gain significance in
patients with a more complex risk profile.
We are indebted to J. Kunert for his help in statistical evalua-
tion. We thank M. Hoffmann for his assistance in the preparation
of the manuscript.
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